Skip to main content
Metal-Based Drugs logoLink to Metal-Based Drugs
. 1996;3(3):155–160. doi: 10.1155/MBD.1996.155

Boronated Pyrimidines and Purines as Cytotoxic, Hypolipidemic and Anti-Inflammatory Agents

Iris H Hall 1,, Bruce S Burnham 1, Amy Elkins 1, Anup Sood 2, Walda Powell 2, Jeno Tomasz 2, Bernard F Spielvogel 2
PMCID: PMC2365016  PMID: 18472811

Abstract

The simple boronated bases, e.g. cytosine, adenine and guanine, containing no sugar residues retained good pharmacological activity as hypolipidemic, anti-neoplastic and anti-inflammatory agents in mice at 8 mg/kg. Their activities were generally identical to their respective nucleoside derivatives. Interestingly the boronated acyclovir derivative was a very potent hypolipidemic agent achieving better activity than clofibrate and lovastatin. The boronated adenine derivatives appeared to have the best anti-inflammatory activity in reducing local edema and analgesic effects. The agents were active against the growth of murine and human leukemias and human HeLa-S3 suspended uterine carcinoma. Only the boronated adenine derivatives were effective in blocking the growth of human SW480 adenocarcinoma and the KB nasopharynx.

Full Text

The Full Text of this article is available as a PDF (773.4 KB).


Articles from Metal-Based Drugs are provided here courtesy of Wiley

RESOURCES